Hydrogen Sulfide (HS)-Releasing Compounds: Therapeutic Potential in Cardiovascular Diseases

about

Hydrogen Sulfide (HS)-Releasing Compounds: Therapeutic Potential in Cardiovascular Diseases

Item

http://www.wikidata.org/entity/Q57300054

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

наукова стаття, опублікована у 2018

@uk

name

Hydrogen Sulfide (HS)-Releasin ...... ial in Cardiovascular Diseases

@en

type

Item

label

Hydrogen Sulfide (HS)-Releasin ...... ial in Cardiovascular Diseases

@en

prefLabel

Hydrogen Sulfide (HS)-Releasin ...... ial in Cardiovascular Diseases

@en

P1476

Hydrogen Sulfide (HS)-Releasin ...... ial in Cardiovascular Diseases

@en

P2093

Lei Zhang

http://www.w3.org/2001/XMLSchema#string

Lingli Li

http://www.w3.org/2001/XMLSchema#string

Sheng Liu

http://www.w3.org/2001/XMLSchema#string

Suowen Xu

http://www.w3.org/2001/XMLSchema#string

Xiaojun Feng

http://www.w3.org/2001/XMLSchema#string

Yanan Wang

http://www.w3.org/2001/XMLSchema#string

Yi Li

http://www.w3.org/2001/XMLSchema#string

P2860

Structural basis for the inhibition mechanism of human cystathionine gamma-lyase, an enzyme responsible for the production of H(2)S

MicroRNAs: target recognition and regulatory functions

Mammalian Krüppel-like factors in health and diseases

Hydrogen sulfide inhibits the development of atherosclerosis with suppressing CX3CR1 and CX3CL1 expression

Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning

Krüppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling

H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase

The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener

Cardioprotective effects of a novel hydrogen sulfide agent-controlled release formulation of S-propargyl-cysteine on heart failure rats and molecular mechanisms

S-Propargyl-Cysteine, a Novel Hydrogen Sulfide Donor, Inhibits Inflammatory Hepcidin and Relieves Anemia of Inflammation by Inhibiting IL-6/STAT3 Pathway

P304

1066

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2018.01066

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30298008

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

cardiovascular disease

P932

6160695

http://www.w3.org/2001/XMLSchema#string